<DOC>
	<DOC>NCT00412555</DOC>
	<brief_summary>This study will evaluate the safety of Tamiflu, when used for the prevention of influenza in children during the flu season. Children who would benefit from influenza prophylaxis when influenza is circulating in the community will receive treatment with Tamiflu syrup (or capsules) 30mg-75mg once daily (dependent on body weight) for 6 weeks. Safety data and influenza symptoms will be recorded throughout the study. The anticipated time on study treatment is &lt;3 months, and the target sample size is &lt;100 individuals.</brief_summary>
	<brief_title>A Study of Tamiflu (Oseltamivir) for Seasonal Prophylaxis of Influenza in Children.</brief_title>
	<detailed_description />
	<mesh_term>Influenza, Human</mesh_term>
	<mesh_term>Oseltamivir</mesh_term>
	<criteria>males or females, 112 years of age; candidate for seasonal prophylaxis; negative rapid diagnostic test for influenza at baseline. symptoms suggestive of influenzalike illness; positive rapid diagnostic test for influenza; antiviral treatment for influenza in 2 weeks prior to randomization.</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>